Status:
UNKNOWN
OPHTHALMOLOGIC EVALUATION OF RADIATION-RELATED OPTIC NEUROPATHY FOLLOWING IMAGE GUIDED INTENSITY-MODULATED RADIATION THERAPY (IMRT) FOR NASOPHARYNGEAL CARCİNOMA
Lead Sponsor:
Istanbul University - Cerrahpasa
Conditions:
The Aim of Our Study is to Prospectively Evaluate the Optic Neuropathy in Nasopharynx Cancer Patients
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Primary treatment in nasopharynx cancers is radiotherapy (RT) or chemoradiotherapy (CRT) depending on the stage of the tumor. According to the guidelines, the dose of radiotherapy for primary tumors v...
Eligibility Criteria
Inclusion
- Patient with nasopharyngeal carcinoma that histopathologically confirmed Age \>18 Radiotherapy or chemoradiotherapy applied to the patient in our clinic No recurrence or metastasis during follow-up Optic evaluation Evaluation with MRI or CT during follow-up
Exclusion
- Cranial RT No histopathological verification Age\< 18 There were locoregional recurrence or metastasis
Key Trial Info
Start Date :
December 3 2020
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
May 3 2021
Estimated Enrollment :
15 Patients enrolled
Trial Details
Trial ID
NCT04724590
Start Date
December 3 2020
End Date
May 3 2021
Last Update
January 26 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Meltem Dağdelen
Istanbul, Turkey (Türkiye), 34096